Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Buy Rating on Eastman Chemical with Positive Outlook

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Neurotechnology
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On February 6, 2024, Patrick Cunningham, an analyst at Citigroup, expressed his positive sentiment towards Eastman Chemical (NYSE:EMN) by maintaining a Buy rating on the stock. Although he adjusted the price target from $96 to $95, this modification does not diminish his optimistic outlook on the company. Cunningham’s consistent recommendation to Buy EMN shares further reinforces his bullish stance. The consensus target price for Eastman Chemical stands at $96.56, indicating an outperform rating. The stock also boasts a high price target of $130 and a low price target of $78.

EMN Stock: Mixed Performance with After-Hours Drop on February 6, 2024

On February 6, 2024, EMN stock, the ticker symbol for Eastman Chemical Company, experienced mixed performance throughout the day. EMN stock was trading in the middle of its 52-week range on that day and near its 200-day simple moving average, indicating that the stock’s price was in line with its long-term trend. The price of EMN shares saw a slight increase of $0.08 since the market last closed on February 5, 2024, bringing the closing price of EMN stock to $82.61. However, after the market closed, EMN stock experienced a drop of $0.63 in after-hours trading. This drop in price during after-hours trading suggests that there may have been some negative news or market sentiment surrounding EMN, leading to a decline in its value. It is important to note that after-hours trading can be more volatile and have lower liquidity compared to regular trading hours. Investors and analysts closely monitor after-hours trading to gauge the market’s reaction to news releases, earnings reports, or other significant events that occur outside regular trading hours. In conclusion, on February 6, 2024, EMN stock showed mixed performance, with a slight increase during regular trading hours and a decline in after-hours trading.

Eastman Chemical Company (EMN) Demonstrates Steady Financial Performance in the Stock Market

On February 6, 2024, Eastman Chemical Company (EMN) displayed a steady performance in the stock market. The company’s financial data reveals that EMN has maintained consistent figures in terms of total revenue, net income, and earnings per share. EMN reported a total revenue of $9.21 billion over the past year, which is a decrease of 12.58% compared to the previous year. However, the company’s total revenue remained flat since the last quarter. EMN recorded a net income of $894 million over the past year, representing an increase of 12.74% compared to the previous year. Similar to the total revenue, the net income held flat since the last quarter. The earnings per share (EPS) for EMN stood at $7.49 over the past year, displaying an increase of 17.97% compared to the previous year. However, the EPS witnessed a significant surge of 74.49% since the last quarter. Overall, EMN’s stock performance on February 6, 2024, showcased stability and consistency in its financial metrics. Investors and analysts will likely analyze these figures to evaluate EMN’s performance and make informed decisions regarding their investments.

Tags: EMN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Cup of coffee

Revolutionizing Sports Streaming Disney Warner Bros and Fox Join Forces

Radio telecommunications

Gina Carano Files Lawsuit Against Disney and Lucasfilm Implications for the Entertainment Industry

GLPIs Acquisition of Tioga Downs Casino Resort A Path to Growth and Success

Recommended

NTSB Investigative Hearing Raises Concerns About Boeing 737 Max 9 Safety Practices

2 years ago
Immunovant Inc Stock

Immunovant’s Critical Juncture: All Eyes on September Catalyst

6 months ago
Plug Power Stock

Plug Power’s Contradiction: Operational Gains Versus Market Pessimism

6 months ago
Grayscale Bitcoin Stock

Bitcoin ETFs Face Mounting Pressure as Prices Plunge Below Key Threshold

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

Trending

Independent Bank Stock
Analysis

Independent Bank Shares Approach Peak Amid Insider Selling

by Rodolfo Hanigan
February 7, 2026
0

The stock of Independent Bank Corp. presents a notable market contradiction. Trading near its 52-week peak, the...

Communications Stock

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Hbt Financial Stock

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Independent Bank Shares Approach Peak Amid Insider Selling
  • The Race to Rewire: Fiber Optics Reshape the Telecom Landscape
  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com